ValiRx plc (AIM:VAL)
London · Delayed Price · Currency is GBP · Price in GBX 0.1300
+0.0050 (4.00%)
Sep 25, 2026, 3:40 PM GMT
ValiRx Market Cap
ValiRx has a market cap or net worth of 1.65 million as of September 25, 2026. Its market cap has decreased by -29.46% in one year.
Market Cap
1.65M
Enterprise Value
193.94K
Revenue
32.67K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
ChartMarket Cap Chart
Since October 3, 2006, ValiRx's market cap has decreased from 12.83M to 1.65M, a decrease of -87.14%. That is a compound annual growth rate of -9.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 1.65M | -33.67% |
| Dec 31, 2025 | 2.49M | -14.24% |
| Dec 31, 2024 | 2.90M | -51.94% |
| Dec 29, 2023 | 6.04M | -33.71% |
| Dec 30, 2022 | 9.11M | -61.38% |
| Dec 31, 2021 | 23.58M | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aptamer Group | 11.23M |
| Solvonis Therapeutics | 7.83M |
| CRISM Therapeutics | 7.72M |
| Thalia Therapeutics | 7.25M |
| Cizzle Biotechnology Holdings | 7.22M |
| OptiBiotix Health | 6.04M |
| Theracryf | 4.64M |
| Nuformix | 3.52M |